Facebook
X
LinkedIn
ForwardAASLD Meeting Review 2025
This update will be presented by members of the hepatology team from the Division of Gastroenterology and Hepatology at the Medical College of Wisconsin. This review will include diverse topics such as Metabolic dysfunction-associated liver diseases, Alcohol related liver diseases, Portal hypertension, Non-invasive tests for diagnosis of liver diseases and liver biopsies, What is new in MASLD and portal hypertension management, What is new in management of autoimmune liver diseases, and When to refer the patient for liver transplant evaluation. There will be plenty of time for questions and answers.
Target Audience
Gastroenterologists, Hepatologists, Nurse Practitioners and Physician Assistants
Learning Objectives
Participants who engage in this educational intervention will be able to:
- Identify patients at risk for progression of metabolic dysfunction associated steatotic liver disease and how to initiate different interventions.
- Recognize when to refer a patient for liver transplantation.
- Recognize treatment failure early in patients on treatment for autoimmune hepatitis and address it.
AASLD 2025 Meeting Review
January 31, 2026
Course Director: Achuthan Souria, MD, MRCP
7:30-8:00 Registration and Continental Breakfast
8:00-8:05 Welcome
José Franco, MD
8:05-8:30 Metabolic dysfunction-associated liver diseases
Achuthan Sourianarayanane, MD, MRCP
8:30-8:55 Alcohol related liver diseases
Rituparna Medda, DO
8:55-9:20 Portal Hypertension
Achuthan Sourianarayanane, MD, MRCP
9:20-9:35 BREAK
9:35-9:55 Non-invasive tests for diagnosis of liver diseases and liver biopsies
Rituparna Medda, DO
9:55-10:25 Management of biliary disease in chronic liver diseases
Srivats Madhavan, MBBS
10:25-11:00 What is new in MASLD and portal hypertension management
Achuthan Sourianarayanane, MD, MRCP
11:00-11:20 BREAK
11:20-11:40 What is new in the management of autoimmune liver diseases
Kia Saeian, MD, MSc, Epi
11:40-12:00 When to refer the patient for liver transplant evaluation
Phaedra Tachtatzis, MBChB, MRCP, MD
12:00-12:15 Summary and Wrap-Up
12:15 LUNCH
Activity Directors:
In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 3.25 hours of participation for continuing education for allied health professionals.
Available Credit
- 3.25 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 3.25 Hours of ParticipationHours of Participation credit.
Salix Pharmaceutical
Madrigol Pharmaceutical
Gilead Pharmaceutical
Mallinckrodt Pharmaceutical
Ipsen Pharmaceutical